Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on creation of ISIN with NSDL
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures has been allotted and activated an ISIN (INE771F13020) by NSDL for fully convertible warrants that were allotted on 18th February 2025. This is a procedural disclosure under SEBI LODR Regulation 30, confirming the warrants now have a unique identification number for depository tracking. The scrip code on BSE is 524743 and the company was formerly known as Fischer Chemic Limited.
For shareholders, this is a routine regulatory update enabling the warrants to be processed and potentially converted into equity shares in the future. It does not signal any immediate change in shareholding or price, but investors should track the warrant conversion timeline as it could lead to equity dilution.